The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway

The pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiqu...

Full description

Bibliographic Details
Main Authors: Peng Liu, Songbai Liu, Changhao Zhu, Yongning Li, Ying Li, Xiaobin Fei, Junyi Hou, Xing Wang, Yaozhen Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/full
_version_ 1797834699920375808
author Peng Liu
Peng Liu
Songbai Liu
Changhao Zhu
Yongning Li
Ying Li
Xiaobin Fei
Junyi Hou
Xing Wang
Xing Wang
Yaozhen Pan
Yaozhen Pan
author_facet Peng Liu
Peng Liu
Songbai Liu
Changhao Zhu
Yongning Li
Ying Li
Xiaobin Fei
Junyi Hou
Xing Wang
Xing Wang
Yaozhen Pan
Yaozhen Pan
author_sort Peng Liu
collection DOAJ
description The pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiquitinating enzyme, in PC is still unclear. In this study, we found that MINDY2 expression is elevated in PC tissue (clinical samples) and was associated with poor prognosis. We also found that MINDY2 is associated with pro-carcinogenic factors such as epithelial-mesenchymal transition (EMT), inflammatory response, and angiogenesis; the ROC curve suggested that MINDY2 has a high diagnostic value in PC. Immunological correlation analysis suggested that MINDY2 is deeply involved in immune cell infiltration in PC and is associated with immune checkpoint-related genes. In vivo and in vitro experiments further suggested that elevated MINDY2 promotes PC proliferation, invasive metastasis, and EMT. Meanwhile, actinin alpha 4 (ACTN4) was identified as a MINDY2-interacting protein by mass spectrometry and other experiments, and ACTN4 protein levels were significantly correlated with MINDY2 expression. The ubiquitination assay confirmed that MINDY2 stabilizes the ACTN4 protein level by deubiquitination. The pro-oncogenic effect of MINDY2 was significantly inhibited by silencing ACTN4. Bioinformatics Analysis and Western blot experiments further confirmed that MINDY2 stabilizes ACTN4 through deubiquitination and thus activates the PI3K/AKT/mTOR signaling pathway. In conclusion, we identified the oncogenic role and mechanism of MINDY2 in PC, suggesting that MINDY2 is a viable candidate gene for PC and may be a therapeutic target and critical prognostic indicator.
first_indexed 2024-04-09T14:42:50Z
format Article
id doaj.art-d5709f8042224d4e909d95ef8e83989f
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T14:42:50Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-d5709f8042224d4e909d95ef8e83989f2023-05-03T05:23:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.11698331169833The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathwayPeng Liu0Peng Liu1Songbai Liu2Changhao Zhu3Yongning Li4Ying Li5Xiaobin Fei6Junyi Hou7Xing Wang8Xing Wang9Yaozhen Pan10Yaozhen Pan11College of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaCollege of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, ChinaThe pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiquitinating enzyme, in PC is still unclear. In this study, we found that MINDY2 expression is elevated in PC tissue (clinical samples) and was associated with poor prognosis. We also found that MINDY2 is associated with pro-carcinogenic factors such as epithelial-mesenchymal transition (EMT), inflammatory response, and angiogenesis; the ROC curve suggested that MINDY2 has a high diagnostic value in PC. Immunological correlation analysis suggested that MINDY2 is deeply involved in immune cell infiltration in PC and is associated with immune checkpoint-related genes. In vivo and in vitro experiments further suggested that elevated MINDY2 promotes PC proliferation, invasive metastasis, and EMT. Meanwhile, actinin alpha 4 (ACTN4) was identified as a MINDY2-interacting protein by mass spectrometry and other experiments, and ACTN4 protein levels were significantly correlated with MINDY2 expression. The ubiquitination assay confirmed that MINDY2 stabilizes the ACTN4 protein level by deubiquitination. The pro-oncogenic effect of MINDY2 was significantly inhibited by silencing ACTN4. Bioinformatics Analysis and Western blot experiments further confirmed that MINDY2 stabilizes ACTN4 through deubiquitination and thus activates the PI3K/AKT/mTOR signaling pathway. In conclusion, we identified the oncogenic role and mechanism of MINDY2 in PC, suggesting that MINDY2 is a viable candidate gene for PC and may be a therapeutic target and critical prognostic indicator.https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/fullpancreatic cancerMINDY2deubiquitinating enzymeACTN4PI3K/AKT/mTOR
spellingShingle Peng Liu
Peng Liu
Songbai Liu
Changhao Zhu
Yongning Li
Ying Li
Xiaobin Fei
Junyi Hou
Xing Wang
Xing Wang
Yaozhen Pan
Yaozhen Pan
The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
Frontiers in Oncology
pancreatic cancer
MINDY2
deubiquitinating enzyme
ACTN4
PI3K/AKT/mTOR
title The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
title_full The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
title_fullStr The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
title_full_unstemmed The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
title_short The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
title_sort deubiquitinating enzyme mindy2 promotes pancreatic cancer proliferation and metastasis by stabilizing actn4 expression and activating the pi3k akt mtor signaling pathway
topic pancreatic cancer
MINDY2
deubiquitinating enzyme
ACTN4
PI3K/AKT/mTOR
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/full
work_keys_str_mv AT pengliu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT pengliu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT songbailiu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT changhaozhu thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yongningli thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yingli thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT xiaobinfei thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT junyihou thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT xingwang thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT xingwang thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yaozhenpan thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yaozhenpan thedeubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT pengliu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT pengliu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT songbailiu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT changhaozhu deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yongningli deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yingli deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT xiaobinfei deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT junyihou deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT xingwang deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT xingwang deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yaozhenpan deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway
AT yaozhenpan deubiquitinatingenzymemindy2promotespancreaticcancerproliferationandmetastasisbystabilizingactn4expressionandactivatingthepi3kaktmtorsignalingpathway